T1结直肠癌内镜R1/Rx切除后下一步该怎么办
T1癌常未被识别,导致内镜切除技术选择不当,出现切缘阳性(R1)或无法评估(Rx)。Gijsbers等比较全层切除与补做手术的肿瘤学结局,发现全层切除组结直肠癌复发率显著更高(9.0% vs 2.2%),但两组无转移生存率和总生存率无显著差异,结果支持对Rx/R1切缘且其他低风险肿瘤将疤痕全层切除作为一线方法。
要点
- T1癌常未被识别,内镜切除技术选择不当导致R1或Rx切缘。
- 疤痕全层切除组结直肠癌复发率9.0%,补做手术组2.2%,前者显著更高。
- 两组无转移生存率和总生存率无显著差异,结果支持对低风险Rx/R1肿瘤首选疤痕全层切除。
核心结论
- 该研究结果支持对Rx/R1切缘且其他低风险肿瘤将疤痕全层切除作为一线方法。
研究设计与样本
- Gijsbers等开展比较研究,对比疤痕全层切除与补做手术两种策略的肿瘤学结局。
主要发现
- 疤痕全层切除组结直肠癌复发率9.0%,补做手术组2.2%,前者显著更高。
- 两组无转移生存率和总生存率均无显著差异。
临床怎么用
- 作者认为,对Rx/R1切缘且其他低风险的肿瘤,疤痕全层切除可作为一线方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T1 carcinoma is often not recognized as such, and inappropriate endoscopic resection techniques are selected, resulting in positive (R1) or nonassessable (Rx) resection margins. Full-thickness resection has been proposed as an alternative to completion surgery. Gijsbers et al. compared oncological outcomes of both strategies. The main finding was that colorectal cancer recurrence was significantly higher in the full-thickness excision of the scar compared with the completion surgery group (9.0% vs 2.2%). However, metastasis-free survival and overall survival were not significantly different in both groups. The results of this study favor full-thickness excision of the scar as the first-line approach for Rx/R1-resected margins but otherwise low-risk tumors.
引用
- Schmidt A, Neeff HP, Quante M, et al. Endoscopic R1/Rx Resection of T1 Colorectal Cancer-What Next? Am J Gastroenterol. 2022. PMID: 35103021. doi:10.14309/ajg.0000000000001670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。